The Link Between Unpredictable Chronic Mild Stress Model for Depression and Vascular Inflammation?

[1]  Y. Yazır,et al.  The effect of etanercept on aortic nitric oxide-dependent vasorelaxation in an unpredictable chronic, mild stress model of depression in rats. , 2013, European journal of pharmacology.

[2]  F. Balcı,et al.  Chronic Administration of Infliximab (TNF‐α Inhibitor) Decreases Depression and Anxiety‐like Behaviour in Rat Model of Chronic Mild Stress , 2013, Basic & clinical pharmacology & toxicology.

[3]  Y. Yazır,et al.  Inhibition of Neuronal Nitric Oxide Synthase and Soluble Guanylate Cyclase Prevents Depression‐Like Behaviour in Rats Exposed to Chronic Unpredictable Mild Stress , 2012, Basic & clinical pharmacology & toxicology.

[4]  Lei Zhang,et al.  Unpredictable Chronic Mild Stress Promotes Atherosclerosis in High Cholesterol–Fed Rabbits , 2012, Psychosomatic medicine.

[5]  V. Camus,et al.  Fluoxetine Effect on Aortic Nitric Oxide-Dependent Vasorelaxation in the Unpredictable Chronic Mild Stress Model of Depression in Mice , 2012, Psychosomatic medicine.

[6]  V. Camus,et al.  Altered aortic vascular reactivity in the unpredictable chronic mild stress model of depression in mice UCMS causes relaxation impairment to ACh , 2011, Physiology & Behavior.

[7]  N. Herrmann,et al.  A Meta-Analysis of Cytokines in Major Depression , 2010, Biological Psychiatry.

[8]  L. Naldi,et al.  Epidemiology of comorbidities in psoriasis , 2010, Dermatologic therapy.

[9]  S. Frisbee,et al.  Depressive behavior and vascular dysfunction: a link between clinical depression and vascular disease? , 2010, Journal of applied physiology.

[10]  J. McNeill,et al.  Chronic etanercept treatment prevents the development of hypertension in fructose-fed rats , 2009, Molecular and Cellular Biochemistry.

[11]  J. Suls,et al.  Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis , 2009, Psychosomatic medicine.

[12]  Philip D. Harvey,et al.  New insights into the link between cardiovascular disease and depression , 2007, International journal of clinical practice.

[13]  F. Wolfe,et al.  Comorbidities in rheumatoid arthritis. , 2007, Best practice & research. Clinical rheumatology.

[14]  A. Wykrętowicz,et al.  Impairment of Endothelial Function in Unipolar and Bipolar Depression , 2006, Biological Psychiatry.

[15]  P. Willner.  Chronic Mild Stress (CMS) Revisited: Consistency and Behavioural-Neurobiological Concordance in the Effects of CMS , 2005, Neuropsychobiology.

[16]  G. Plante.  Depression and cardiovascular disease: a reciprocal relationship. , 2005, Metabolism: clinical and experimental.

[17]  J. Davidson,et al.  Nonpharmacologic Treatments for Depression in Patients With Coronary Heart Disease , 2005, Psychosomatic medicine.

[18]  J. Francis,et al.  Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia , 2005, Physiology & Behavior.

[19]  Andrew H. Miller,et al.  Cytokines and psychopathology: Lessons from interferon-α , 2004, Biological Psychiatry.

[20]  G. Baker,et al.  Nitric oxide: a key player in the relation between cardiovascular disease and major depressive disorder? , 2004, Journal of psychiatry & neuroscience : JPN.

[21]  S. Archer,et al.  Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder , 2004, Biological Psychiatry.

[22]  P. López-Jaramillo,et al.  Angiotensin II-induced MMP-2 release from endothelial cells is mediated by TNF-α , 2004 .

[23]  Y. Pollak,et al.  Cytokine-induced changes in mood and behaviour: implications for 'depression due to a general medical condition', immunotherapy and antidepressive treatment. , 2002, The international journal of neuropsychopharmacology.

[24]  P. Ganz,et al.  Endothelial function. From vascular biology to clinical applications. , 2002, The American journal of cardiology.

[25]  C. Jones,et al.  Arterial endothelial function is impaired in treated depression , 2002, Heart.

[26]  F. Ruschitzka,et al.  Anti–Tumor Necrosis Factor-α Treatment Improves Endothelial Function in Patients With Rheumatoid Arthritis , 2002 .

[27]  S. Fichtlscherer,et al.  Tumor Necrosis Factor Antagonism With Etanercept Improves Systemic Endothelial Vasoreactivity in Patients With Advanced Heart Failure , 2001, Circulation.

[28]  P. Willner.  Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation , 1997, Psychopharmacology.

[29]  M. Yoshizumi,et al.  Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. , 1993, Circulation research.

[30]  Richard Muscat,et al.  Chronic mild stress-induced anhedonia: A realistic animal model of depression , 1992, Neuroscience & Biobehavioral Reviews.

[31]  Cullen B. Owens,et al.  Superoxide responses of endothelial cells to C5a and TNF-alpha: divergent signal transduction pathways. , 1992, The American journal of physiology.

[32]  L. Ignarro,et al.  Activation of purified soluble guanylate cyclase by protoporphyrin IX. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[33]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[34]  J. Kastelein,et al.  Tumor necrosis factor-alpha inhibition protects against endotoxin-induced endothelial glycocalyx perturbation. , 2009, Atherosclerosis.

[35]  Z. Ungvari,et al.  Vasculoprotective effects of anti-tumor necrosis factor-alpha treatment in aging. , 2007, The American journal of pathology.

[36]  P. López-Jaramillo,et al.  Angiotensin II-induced MMP-2 release from endothelial cells is mediated by TNF-alpha. , 2004, American journal of physiology. Cell physiology.

[37]  Andrew H. Miller,et al.  Cytokines and psychopathology: lessons from interferon-alpha. , 2004, Biological psychiatry.

[38]  A. Steptoe,et al.  Psychosocial factors in the development of coronary artery disease. , 2004, Progress in cardiovascular diseases.

[39]  P. Black,et al.  Stress, inflammation and cardiovascular disease. , 2002, Journal of psychosomatic research.

[40]  F. Ruschitzka,et al.  Anti–Tumor Necrosis Factor-&agr; Treatment Improves Endothelial Function in Patients With Rheumatoid Arthritis , 2002, Circulation.